Amanda Wilderman
Adult Medicine · Carbondale, ILNPI 1659915171
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.7% of the total across 154 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 21.7% — the pattern of someone who eats at a lot of different presentations.
Across 154 payments — averaging $18.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$612
- Phathom Pharmaceuticals, Inc.$332
- Aimmune Therapeutics, Inc.$172
- Ardelyx, Inc.$163
- Gilead$157
- Intercept Pharmaceuticals, Inc.$154
- plus $1K from 17 others
What the payments were for
- Food & beverage$2,76398%
- Education$151%
- Gifts$502%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 38 | $612 |
| Phathom Pharmaceuticals, Inc. | 22 | $332 |
| Aimmune Therapeutics, Inc. | 8 | $172 |
| Ardelyx, Inc. | 8 | $163 |
| Gilead | 8 | $157 |
| Intercept Pharmaceuticals, Inc. | 6 | $154 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $148 |
| Braintree Laboratories, Inc. | 9 | $147 |
| QOL Medical, LLC | 9 | $145 |
| Sanofi | 4 | $99 |
| Celltrion USA Inc. | 6 | $97 |
| Regeneron Healthcare Solutions, Inc. | 3 | $93 |
| Ipsen Biopharmaceuticals, Inc | 4 | $90 |
| Lilly USA, LLC | 3 | $77 |
| Pfizer | 4 | $62 |
| Merck | 3 | $54 |
| Madrigal Pharmaceuticals | 3 | $53 |
| Johnson & Johnson | 2 | $50 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $36 |
| Nestle Healthcare Nutrition Inc. | 2 | $35 |
| Boehringer Ingelheim | 1 | $19 |
| Alfasigma USA, Inc. | 1 | $18 |
| Bristol Myers Squibb | 1 | $16 |
How this compares
$2,828 in reported general payments places this provider in the 85th percentile of 39 adult medicine providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RezdiffraResmetirom | 12 | $49,035 |
| LinzessLinaclotide | 33 | $26,608 |
| MounjaroTirzepatide | 21 | $21,853 |
| OzempicSemaglutide | 14 | $11,948 |
| Omeprazole | 241 | $2,384 |
| Esomeprazole Magnesium | 34 | $2,282 |
| Pantoprazole Sodium | 75 | $792 |
| Sucralfate | 18 | $634 |
| Dicyclomine Hcl | 39 | $501 |
| Famotidine | 29 | $435 |
| Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine | 11 | $339 |
| Metoclopramide Hcl | 35 | $160 |
| Hydrocortisone | 12 | $151 |
| Ondansetron OdtOndansetron | 13 | $143 |
| Procto-Med HcHydrocortisone | 12 | $131 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Madrigal PharmaceuticalsRezdiffra | $53 | $49,03512 claims |
| AbbVieLinzess | $612 | $26,60833 claims |
| Lilly USA, LLCMounjaro | $77 | $21,85321 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 39 adult medicine providers in Illinois.
Other adult medicine in Carbondale
- Gary BucherChicago$54K
- Thomas KleinChicago$27K
- Ross SlottenChicago$5K
- Nereida RojasChicago$4K
- Josephine ManteAurora$1K
- Josie TenoreHighland Park$1K
- Sofiya EltermanBuffalo Grove$769
- June LeeCrest Hill$672
- Konstantins KociasviliGlenview$534
- Wesley HarmstonChicago$277
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.